<p id="P12">We then considered whether <CELL_LINE>COT-expressing cancer cells</CELL_LINE> remain sensitive to <PATHWAY>MAPK pathway</PATHWAY> inhibition at a target downstream of <GENE_PROTEIN>COT</GENE_PROTEIN> or <PROTEIN_FAMILY>RAF</PROTEIN_FAMILY>. Here, we queried the <CELL_LINE>OUMS-23</CELL_LINE> and <CELL_LINE>RPMI-7951</CELL_LINE> cell lines for sensitivity to the <DRUG_CLASS>MEK1/2 inhibitor</DRUG_CLASS> <DRUG>CI-1040</DRUG>. Interestingly, <CELL_LINE normalization="OUMS-23"><CELL_LINE normalization="RPMI-7951">both cell lines</CELL_LINE></CELL_LINE> were refractory to <PROTEIN_FAMILY>MEK</PROTEIN_FAMILY> inhibition (<xref ref-type="fig" rid="F4">Fig. 4a</xref>) and displayed sustained <PROTEIN_FAMILY>ERK</PROTEIN_FAMILY> phosphorylation even at 1 µM CI-1040 (<xref ref-type="fig" rid="F4">Fig. 4b</xref>). Ectopic <GENE_PROTEIN>COT</GENE_PROTEIN> expression in <CELL_LINE>A375</CELL_LINE> and <CELL_LINE>SKMEL28</CELL_LINE> cells also conferred decreased sensitivity to the <DRUG_CLASS>MEK inhibitors</DRUG_CLASS> <DRUG>CI-1040</DRUG> and <DRUG>AZD6244</DRUG>, suggesting that <GENE_PROTEIN>COT</GENE_PROTEIN> expression alone was sufficient to induce this phenotype (<xref ref-type="fig" rid="F4">Fig. 4c, 4d</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 17</xref>). Similar to results observed with <DRUG_CLASS>pharmacological MEK inhibitors</DRUG_CLASS>, <GENE_PROTEIN normalization="MEK2"><GENE_PROTEIN normalization="MEK1">MEK1</GENE_PROTEIN>/2</GENE_PROTEIN> knockdown only modestly suppressed <GENE_PROTEIN>COT</GENE_PROTEIN>–mediated <PROTEIN_FAMILY>ERK</PROTEIN_FAMILY> phosphorylation in <CELL_LINE>A375</CELL_LINE> cells (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 18</xref>). In accordance with prior observations<xref ref-type="bibr" rid="R24">24</xref>, these data raised the possibility that <GENE_PROTEIN>COT</GENE_PROTEIN> may activate <PROTEIN_FAMILY>ERK</PROTEIN_FAMILY> through <PROTEIN_FAMILY>MEK</PROTEIN_FAMILY>-independent and <PROTEIN_FAMILY>MEK</PROTEIN_FAMILY>-dependent mechanisms. To test this hypothesis directly, we performed an <italic>in vitro</italic> kinase assay using recombinant <GENE_PROTEIN>COT</GENE_PROTEIN> and <GENE_PROTEIN>ERK1</GENE_PROTEIN>. Indeed, recombinant <GENE_PROTEIN>COT</GENE_PROTEIN> induced pThr202/Tyr204 phosphorylation of <GENE_PROTEIN>ERK1</GENE_PROTEIN> <italic>in vitro</italic> (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 18</xref>) suggesting that in certain contexts, <GENE_PROTEIN>COT</GENE_PROTEIN> expression may potentiate <PROTEIN_FAMILY>ERK</PROTEIN_FAMILY> activation in a <PROTEIN_FAMILY>MEK</PROTEIN_FAMILY>-independent manner.</p>